The anti-Tim antibody was provided by P. Minoo (S8) . The anti-Fbxl3 antibody was produced in rabbit by immunization with a peptide corresponding to aa 228-236 (C-IDDTPVDDP) of human Fbxl3. This region has high antigenic index and does not show homology to other proteins in the database. A polyclonal antibody against Fbxl10 was generated by immunizing rabbits with a peptide containing amino acids 800-1000 of human Fbxl10. Rabbit polyclonal antibody against Fbxl11 was raised against a peptide containing amino acids 11-24 of human Fbxl11. Per1, Per2, Cry1, Cry2, Clock , and Bmal1 cDNAs were provided by D.M. Virshup and subcloned in pcDNA3.1. Tim cDNA was provided by J. Takahashi and subcloned into pcDNA3.1. For retrovirus production, cDNAs encoding Fbxl3, βTrcp1, Skp2, Fbxl2, Fbxl10, Fbxl11, Fbxl15, Emi1, Fbxo9, Fbx022, Cry1 , and Cry2 were subcloned into the retroviral vector pBabe and/or pallino (S9). Fbxl3 cDNA was amplified using a 5'oligo encoding the FLAG-HA epitope tag sequence and subsequently cloned in pBabe (S9) . shRNAs targeting human and mouse Fbxl3 were constructed in the Lenti-Lox3.7(pLL3.7) vector. The oligonucleotides used to construct the shRNAs for human Fbxl3 were :
Plasmids and small hairpin RNAs
(#1) 5' TGGACATTATTCTCCAAGTATTCAAGAGATACTTGGAGAATAATGTCCTTTTTTC 3'; and (#2) 5' TGGCCAACAATAGTGATACATTCAAGAGATGTATCACTATTGTTGGCCTTTTTTC 3'.
The oligonucleotides used to construct the shRNAs for mouse Fbxl3 were:
(#1) 5' TGAATTGGAATCAGGTATTTTTCAAGAGAAAATACCTGATTCCAATTCTTTTTTC 3'; (#2) 5' TGGACAGCAGCAAAGAATCATTCAAGAGATGATTCTTTGCTGCTGTCCTTTTTTC 3'; and (#3) 5' TGCTTGTGAATTGCTCTTTATTCAAGAGATAAAGAGCAATTCACAAGCTTTTTTC 3'.
Transient transfections, retrovirus-and lentivirus-mediated DNA transfer
HEK293T cells were transfected using the calcium phosphate method as described (S10). For retrovirus production, packaging GP-293 cells (Clontech) were transfected with FuGENE-6 transfection reagent (Roche) according to the manufacturer's instructions. Forty-eight hours after transfection, the viruscontaining medium was collected and supplemented with 8 µg/ml polybrene (Sigma). Cells were then infected by replacing the cell culture medium with the viral supernatant for six hours. For lentivirus production, HEK293T cells were cotransfected with pLL3.7 and packaging vectors, and the virus-containing medium was collected after 48 -72 hours and supplemented with 8 µg/ml polybrene. Target cells were incubated with the virus twice a day for three hours for two consecutive days.
Recombinant proteins cDNAs encoding the entire coding region of human Fbxl3 and Cry2 were inserted into the baculoviral expression vector pFastBac HTb (Invitrogen). Bacterial vectors for human Ubc3 (His-tagged) (S4), Ubc5 (His-tagged) (S4), and baculoviruses expressing Skp2 (S7), βTrcp1, (S11), Skp1 (His-tagged), Cul1 (HA-tagged), and Roc1 (S7, S12) were previously described. All recombinant proteins were produced in 5B insect cells as described (S13) .
In vitro ubiquitylation assay
The ubiquitylation of Cry2 was performed in a volume of 10 µl containing 50 mM Tris pH 7.6, 5 mM MgCl 2 , 0.6 mM DTT, 2 mM ATP, 1.5 ng/µl E1 (Boston Biochem), 10 ng/µl Ubc3, 10 ng/µl Ubc5, 2.5 µg/µl ubiquitin (Sigma), 1 µM ubiquitin aldehyde, 2 µl of extracts from 5B insect cells expressing human Cry2, Skp1, Cul1, Roc1, and one of the following human F-box proteins: Fbxl3, Skp2, or βTrcp1. In the experiment shown in Fig. 2D , insect cell extracts were substituted with the indicated immunoprecipitates. Where indicated, 2.5 µg/µl methylubiquitin (Boston Biochem) was added instead of ubiquitin. The reactions were incubated at 30°C for the indicated times and analyzed by SDS-PAGE and immunoblotting with an antibody against Cry2.
mRNA Analysis RNA was extracted using the RNeasy Kit (Qiagen). cDNA synthesis was performed using Superscript III (Invitrogen). Quantitative PCR analysis was performed according to standard procedures. Primer sequences were:
Per1, 5' ACCTCAGCCAGCATCACCC 3' and 5' GAAGAGTCGATGCTGCCAAAG 3' Per2, 5' GTCCACCTCCCTGCAGACAAG 3' and 5' GCCTTCACCTGCTTCACGC 3' Cry1, 5' AAGAGGATGCCCAGAGTGTCG 3' and 5' CCTCCCACACGCTTTCGTATC 3' 18S rRNA, 5' CGCCGCTAGAGGTGAAATTC 3' and 5' CTTTCGCTCTGGTCCGTCTT 3'
Chromatin immunoprecipitations NIH3T3 cells were washed twice with PBS and cross-linked with 1% formaldehyde at room temperature for 10 min. Cells then were rinsed with ice-cold PBS twice and sonicated in lysis buffer (1% SDS, 10 mM EDTA, 50 mM Tris-HCl, pH 8.1, and protease inhibitor cocktail) three times for 10 seconds each, followed by centrifugation for 10 minutes. Supernatants were collected and diluted in buffer (1% Triton X-100, 2 mM EDTA, 150 mM NaCl, 20 mM Tris-HCl, pH 8.1) followed by immunoclearing with 2 µg sheared salmon sperm DNA, 20 µl preimmune serum, and protein G-sepharose for 2 hours at 4°C. Immunoprecipitations were performed by incubating the supernatants overnight at 4°C with an anti-FLAG monoclonal antibody. After immunoprecipitation, protein G-Sepharose, and 2 µg of salmon sperm DNA were added, and the incubation was continued for 1 hour. Precipitates were washed sequentially for 10 minutes each in buffer I (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl, pH 8.1, 150 mM NaCl), buffer II (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl, pH 8.1, 500 mM NaCl), and buffer III (0.25 M LiCl, 1% NP-40, 1% deoxycholate, 1 mM EDTA, 10 mM Tris-HCl, pH 8.1). Precipitates were then washed three times with TE buffer and extracted three times with 1% SDS, 0.1 M NaHCO 3 . Eluates were pooled and heated at 65°C for at least 6 hours to reverse the formaldehyde cross-linking. DNA fragments were purified with a QIAquick Spin Kit (Qiagen). Quantitative PCR analysis was performed according to standard procedure. Primers sequences were as reported in (S14):
Per1, 5'-CAGATGCCAGGAAGAGATCCTTAGCCAACC-3' and 5'-GACTAACCCTAGGATTGCAGCAGGGATCC-3'; Per2, 5'-AGCAGCATCTTCATTGAGGAACCCGGG-3' and 5'-CTCCGCTGTCACATAGTGGAAAACGTGAC-3'; Cry1, 5'-CTGCAACCAGCTCGGGCCGTC-3' and 5'-GATGAATGGGAGGCTGCCGAGGC-3' rDNA, 5'-GGAGTGCGATGGTGTGATCT-3' and 5'-TAAAGATTAGCTGGGCGTGG-3' S1 . Purification of the Fbxl3 complex. (A) FLAG-HA-tagged Fbxl3 was retrovirally expressed in HeLa S3 cells and subjected to immunopurification using anti-FLAG agarose and anti-HA resin. The FLAG peptide eluate (FLAG eluate), the flow-through from the second column (HA FT), the HA peptide eluate (HA eluate), and the SDS eluate of the material left on the HA resin (HA beads) were separated by SDS-PAGE and visualized by silver staining. Bands were excised from the lane containing the HA eluate and analyzed by mass spectrometry. The mass spectrometry analysis of proteins co-purified with Fbxl3 revealed the presence of two peptides (FLLQCLEDLDANLR and LTDLYKK) corresponding to Cry1 and three peptides (GQPADVFPR, EFFYTAATNNPR, MKQIYQQLSR) corresponding to both Cry1 and Cry2. As a control, a purification was performed from HeLa S3 cells infected with an empty vector (EV). (B) 3% of the material shown in (A) was analyzed by immunoblotting with an anti-FLAG antibody. The asterisks indicate the immunoglobulin chains. Three hours before lysis, cycloheximide (CHX) was added to the cell culture in the presence or absence of MG132, as indicated. Extracts were then subjected to immunoblotting with antibodies against HA (upper panels) to detect Cry2, against FLAG (middle panels) to detect F-box proteins (FBPs), or against Actin (bottom panels) to show normalization in loading. Fbxl3 . Samples were incubated at 30°C for the indicated time, and reactions were then stopped by the addition of Laemmli sample buffer. Where indicated, methylated ubiquitin was added to the reaction mix. Finally, samples were analyzed by SDS-PAGE and immunoblotting analysis using an antibody against Cry2. The bracket on the left side of the panel marks a ladder of bands corresponding to polyubiquitylated Cry2. When methylated ubiquitin (which is chemically modified to block all of its free amino groups) was added to the in vitro reaction, the abundance of the slowest migrating bands decreased. This effect is due to the capping of polyubiquitin chains by methylated ubiquitin that competes with unmodified ubiquitin and terminates the polyubiquitin chains. This experiment formally demonstrates that the high molecular weight forms of Cry2 are polyubiquitylated species of the protein. fig. S4A ) was used. Cells were asynchronously grown to confluence in a medium containing 10% fetal bovine serum (Asynch.). Asynchronous cells were serum starved for 16 hours and then shifted to a medium containing 50% serum for 90 minutes (50% HS). After this period, the serum-rich medium was replaced with 0.5% serum-containing medium and cells were collected at the indicated hours post-serum shock. Cell extracts were analyzed by immunoblotting with antibodies to the indicated proteins. The experiment with this particular shRNA construct to mouse Fbxl3 was repeated two times with similar results. (B) The graphs illustrate the quantification by densitometry of the results shown in (A). The value given for the amount of Cry1, Per1, and Per2 present in asynchronous cells treated with shRNAs targeting LacZ was set as 100%. fig. S4A ) was used. Cells were asynchronously grown to confluence in a medium containing 10% fetal bovine serum (Asynch.). Asynchronous cells were serum deprived for 16 hours (SD) and then shifted to a medium containing 50% serum for 90 minutes (50% HS). After this period, the serum-rich medium was replaced with 0.5% serumcontaining medium and cells were collected at the indicated hours post-serum shock. Cell extracts were analyzed by immunoblotting with antibodies to the indicated proteins. Retrovirally infected NIH3T3 cells expressing FLAG-tagged Cry1 or un-infected NIH3T3 cells (UI) were infected with lentiviral constructs carrying shRNAs against LacZ or Fbxl3 and subsequently used for chromatin immunoprecipitations using an anti-FLAG antibody. DNA precipitated with the anti-FLAG antibody was amplified by real-time PCR using primers flanking the indicated gene promoters. The unrelated rDNA promoter was used as negative control. The value given for the amount of PCR product present in un-infected NIH3T3 cells was set as 1. Error bars represent + SD (n=3). Asterisks indicate a p value <0.01 measured using a t-test. (which does not target retrovirally expressed human Fbxl3). Twenty-four hours post-infection, cycloheximide (CHX) was added to the cell culture for the indicated times. Finally, cells were collected, and protein extracts were probed with antibodies to the indicated proteins. Human Fbxl3 (which is insensitive to mouse shRNA) reverses the stabilization of Cry1 induced by the shRNA targeting mouse Fbxl3. In contrast, expression of human Fbxl3(C357A) (which is also insensitive to mouse shRNA) is unable to induce the destabilization of Cry1, proving that this mutant is less active than wild-type Fbxl3.
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